Publications in collaboration with researchers from Hospital Clinic Barcelona (11)

2018

  1. Antibiotic selection in the treatment of acute invasive infections by pseudomonas aeruginosa: Guidelines by the Spanish society of chemotherapy

    Revista Espanola de Quimioterapia, Vol. 31, Núm. 1, pp. 78-100

2017

  1. Cost-effectiveness analysis of combination antifungal therapy with voriconazole and anidulafungin versus voriconazole monotherapy for primary treatment of invasive aspergillosis in spain

    ClinicoEconomics and Outcomes Research, Vol. 9, pp. 39-47

2016

  1. La evaluacion de factores de riesgo y el asesoramiento durante 12 meses reduce el riesgo metabolico y cardiovascular en pacientes con trastornos del espectro esquizofrenico con sobrepeso u obesidad: Estudio CRESSOB

    Actas Espanolas de Psiquiatria, Vol. 44, Núm. 1, pp. 20-29

2014

  1. Daptomycin is safe and effective for the treatment of gram-positive cocci infections in solid organ transplantation

    Transplant Infectious Disease, Vol. 16, Núm. 4, pp. 532-538

  2. Prevalence of Metabolic Syndrome in Spanish patients with schizophrenia and overweight. The CRESSOB study

    Actas Espanolas de Psiquiatria, Vol. 42, Núm. 1, pp. 9-17

2013

  1. [Guidelines for antimicrobial treatment of the infection by Staphylococcus aureus].

    Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia, Vol. 26 Suppl 1, pp. 1-84

2011

  1. Update on fungemia in oncology and hematology

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 29, Núm. SUPPL. 4, pp. 42-47

2010

  1. Endotoxin adsortion as adjuvant therapy in gramnegative severe sepsis

    Revista Espanola de Quimioterapia, Vol. 23, Núm. 3, pp. 115-121

2007

  1. Cost-effectiveness analysis of the prevention of relapse of schizophrenia in the ZEUS longitudinal study Ziprasidone Extended Use in Schizphrenia (ZEUS)

    Actas Espanolas de Psiquiatria, Vol. 35, Núm. 4, pp. 259-262

  2. Efficacy and tolerability of prolonged linezolid therapy in the treatment of orthopedic implant infections

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 26, Núm. 5, pp. 353-356

2006

  1. Cost-effectiveness analysis of schizophrenia relapse prevention: An economic evaluation of the ZEUS (Ziprasidone-Extended-Use-in-Schizophrenia) study in Spain

    Clinical Drug Investigation, Vol. 26, Núm. 8, pp. 447-457